Article history: The high hygroscopicity of gentamicin (G) as raw material hampers the production of respirable parti- Received 17 November 2011 cles during aerosol generation and prevents its direct use as powder for inhalation in patients suffering Received in revised form 12 January 2012 from cystic ﬁbrosis (CF). Therefore, this research aimed to design a new dry powder formulation of G Accepted 13 January 2012 studying dispersibility properties of an aminoacid, l-leucine (leu), and appropriate process conditions. Available online 23 January 2012 Spray-dried powders were characterized as to water uptake, particle size distribution, morphology and stability, in correlation with process parameters. Aerodynamic properties were analyzed both by Single Keywords: Stage Glass Impinger and Andersen Cascade Impactor. Moreover, the potential cytotoxicity on bronchial Cystic ﬁbrosis epithelial cells bearing a CFTR F508/F508 mutant genotype (CuFi1) were tested. Results indicated that Gentamicin sulfate leu may improve the aerosol performance of G-dried powders. The maximum ﬁne particle fraction (FPF) l-leucine of about 58.3% was obtained when water/isopropyl alcohol 7:3 system and 15–20% (w/w) of leu were Spray drying Dry powder inhaler used, compared to a FPF value of 13.4% for neat G-dried powders. The enhancement of aerosol efﬁciency CF airway epithelial cells was
International Journal of Pharmaceutics – Elsevier
Published: Apr 15, 2012
It’s your single place to instantly
discover and read the research
that matters to you.
Enjoy affordable access to
over 12 million articles from more than
10,000 peer-reviewed journals.
All for just $49/month
Read as many articles as you need. Full articles with original layout, charts and figures. Read online, from anywhere.
Keep up with your field with Personalized Recommendations and Follow Journals to get automatic updates.
It’s easy to organize your research with our built-in tools.
Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.
All the latest content is available, no embargo periods.
“Hi guys, I cannot tell you how much I love this resource. Incredible. I really believe you've hit the nail on the head with this site in regards to solving the research-purchase issue.”Daniel C.
“Whoa! It’s like Spotify but for academic articles.”@Phil_Robichaud
“I must say, @deepdyve is a fabulous solution to the independent researcher's problem of #access to #information.”@deepthiw
“My last article couldn't be possible without the platform @deepdyve that makes journal papers cheaper.”@JoseServera